We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.72%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$868B
AUM Growth
-$6.92B
Cap. Flow
+$4.82B
Cap. Flow %
0.56%
Top 10 Hldgs %
24.25%
Holding
14,094
New
1,864
Increased
4,890
Reduced
5,380
Closed
1,914

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.23%
2 Technology 1.7%
3 Consumer Discretionary 0.84%
4 Communication Services 0.67%
5 Financials 0.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGNX
11301
CALL
Diginex Ltd
DGNX
$34.9M
$128K ﹤0.01%
+3,850
New +$427K
NEXA icon
11302
PUT
Nexa Resources
NEXA
$1.77B
$128K ﹤0.01%
+14,500
New +$94.4K
SANG
11303
Sangoma Technologies
SANG
$130M
$128K ﹤0.01%
25,373
+1,684
+7% +$8.56K
NMG
11304
PUT
Nouveau Monde Graphite
NMG
$474M
$128K ﹤0.01%
+51,500
New +$151K
SXC icon
11305
CALL
SunCoke Energy
SXC
$862M
$127K ﹤0.01%
+17,700
New +$130K
BULX
11306
DELISTED
GraniteShares 2x Long BULL Daily ETF
BULX
$127K ﹤0.01%
+17,966
New +$235K
FFAI
11307
Faraday Future Intelligent Electric
FFAI
$8.52M
$127K ﹤0.01%
830
-2,691
-76% -$500K
NXN
11308
DELISTED
Nuveen New York Tax-Free Income Portfolio
NXN
$127K ﹤0.01%
+10,513
New +$127K
FDMT icon
11309
PUT
4D Molecular Therapeutics
FDMT
$810M
$127K ﹤0.01%
+16,900
New +$171K
VMD icon
11310
Viemed Healthcare
VMD
$336M
$127K ﹤0.01%
+17,029
New +$117K
SCOR icon
11311
Comscore
SCOR
$78.4M
$126K ﹤0.01%
19,458
-19,606
-50% -$140K
RCS
11312
PIMCO Strategic Income Fund
RCS
$248M
$126K ﹤0.01%
22,694
-7,199
-24% -$50K
AMRX icon
11313
PUT
Amneal Pharmaceuticals
AMRX
$6.11B
$126K ﹤0.01%
+10,000
New +$114K
ENTX icon
11314
Entera Bio
ENTX
$525M
$126K ﹤0.01%
64,910
-2,267
-3% -$5.32K
JRVR icon
11315
James River Group Holdings
JRVR
$191M
$126K ﹤0.01%
19,749
-808
-4% -$4.65K
MORT icon
11316
VanEck Mortgage REIT Income ETF
MORT
$367M
$125K ﹤0.01%
11,929
-20,625
-63% -$218K
NTWK icon
11317
NetSol Technologies
NTWK
$49M
$125K ﹤0.01%
41,300
+30,341
+277% +$111K
ALLO icon
11318
Allogene Therapeutics
ALLO
$698M
$125K ﹤0.01%
91,253
+22,753
+33% +$30K
NMR icon
11319
CALL
Nomura Holdings
NMR
$30.1B
$125K ﹤0.01%
14,900
-5,100
-26% -$38.1K
DSM
11320
BNY Mellon Strategic Municipal Bond Fund
DSM
$288M
$125K ﹤0.01%
20,237
+5,133
+34% +$30.7K
NEWT icon
11321
PUT
NewtekOne
NEWT
$344M
$125K ﹤0.01%
+11,000
New +$120K
RNAC icon
11322
PUT
Cartesian Therapeutics
RNAC
$290M
$125K ﹤0.01%
17,300
+700
+4% +$5.66K
NMS icon
11323
Nuveen Minnesota Quality Municipal Income Fund
NMS
$70.2M
$125K ﹤0.01%
+10,639
New +$127K
PYXS icon
11324
Pyxis Oncology
PYXS
$269M
$125K ﹤0.01%
108,414
-29,117
-21% -$103K
SACH
11325
Sachem Capital Corp
SACH
$42.9M
$124K ﹤0.01%
119,610
-14,004
-10% -$14.9K

Similar funds

Jeff Yass's Q4 2025 Portfolio in Review

As of Q4 2025, Jeff Yass held 14,094 positions worth $868B, down 0.79% from $875B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass's Q4 2025 filing shows 1,864 new, 4,890 increased, 5,380 reduced and 1,914 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.08B.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2025 buy was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M.
  • Jeff Yass added most to Invesco QQQ Trust in Q4 2025, an estimated $1.17B increase.
  • Jeff Yass's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.08B.
  • Jeff Yass fully exited Innovator US Equity Power Buffer ETF September in Q4 2025, selling an estimated $26.5M.
  • Jeff Yass's ten largest holdings make up 24% of its $868B portfolio in Q4 2025.
  • Jeff Yass opened 1,864 new positions and closed 1,914 in Q4 2025.
  • Jeff Yass's portfolio value fell 0.79% quarter-over-quarter to $868B.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.